Eltrombopag treatment for dose-reduction of corticosteroid in corticosteroid dependent adult chronic immune thrombocytopenia (ITP) patients.
Not Applicable
Recruiting
- Conditions
- Corticosteroid Dependent Adult Chronic Immune Thrombocytopenia
- Registration Number
- JPRN-UMIN000011396
- Lead Sponsor
- Hematology/ Oncology, Iwate Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Any history of thrombo-embolic events. 2.Any hereditary disorder that may cause thrombo- embolic events such as ATIII deficiency or Protein C/S deficiency. 3.Any history of allergy/ intolerance to the study drug. 4.Pregnant, possibly pregnant and lactating women as well as women who intend to become pregnant within the proposed study period. 5.Any concomitant drugs or therapy that may influence the result of the study. 6.Renal or hepatic dysfunction/insufficiency. 7. HIV infection, HBV infection 7.Subjects judged as unsuitable for participation in the study for any reason by the physicians in charge of the study. 8.Unable to participate all sessions of the study.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of patients who can replace prednisolone with eltrombopag
- Secondary Outcome Measures
Name Time Method